Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND Beta-hCG
27 results:

  • 1. Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma.
    Pokharel K; Gilbar PJ; Mansfield SK; Nair LM; So A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1266-1269. PubMed ID: 31840564
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A rare case of primary rectal choriocarcinoma and review of the literature.
    Telli TA; Demircan NC; Alan O; Tuylu TB; Arikan R; Ercelep O; Atıcı AE; Ergelen R; Seven IE; Babacan NA; Kaya S; Dane F; Fulden Yumuk P
    J Oncol Pharm Pract; 2020 Jun; 26(4):989-994. PubMed ID: 31547751
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. B Subunit of Human Chorionic Gonadotropin Promotes Tumor Invasion and Predicts Poor Prognosis of Early-Stage colorectal cancer.
    Li J; Yin M; Song W; Cui F; Wang W; Wang S; Zhu H
    Cell Physiol Biochem; 2018; 45(1):237-249. PubMed ID: 29357321
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Discrepant serum and urine β-hCG results due to production of β-hCG by a cribriform-morular variant of thyroid papillary carcinoma.
    Alikhan M; Koshy A; Hyjek E; Stenson K; Cohen RN; Yeo KT
    Clin Chim Acta; 2015 Jan; 438():181-5. PubMed ID: 25181612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement.
    Chen C; Chen LQ; Yang GL; Li Y
    J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia.
    Nelson DW; Cao H; Zhu Y; Sunar-Reeder B; Choi CY; Faix JD; Brown JM; Koong AC; Giaccia AJ; Le QT
    Cancer Res; 2005 Jul; 65(14):6151-8. PubMed ID: 16024616
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Trophoblastic tissue spread to the sigmoid colon after uterine perforation.
    Levin I; Grisaru D; Pauzner D; Almog B
    Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1172-4. PubMed ID: 15516441
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The use of molecular profiling of early colorectal cancer to predict micrometastases.
    Bilchik AJ; Nora DT; Saha S; Turner R; Wiese D; Kuo C; Ye X; Morton DL; Hoon DS
    Arch Surg; 2002 Dec; 137(12):1377-83. PubMed ID: 12470104
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
    Moulton HM; Yoshihara PH; Mason DH; Iversen PL; Triozzi PL
    Clin Cancer Res; 2002 Jul; 8(7):2044-51. PubMed ID: 12114402
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Doctor's dilemma: incorporating tumor markers into clinical decision-making.
    Canil CM; Tannock IF
    Semin Oncol; 2002 Jun; 29(3):286-93. PubMed ID: 12063682
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Significance of endocrine cells and their hormones in colorectal cancer].
    Yin J; Liang Y; Wang H
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):192-5. PubMed ID: 10920894
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Alfthan H; Stenman UH; Roberts PJ
    Br J Cancer; 1996 Sep; 74(6):925-9. PubMed ID: 8826859
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Glassy cell carcinoma of the colon with human chorionic gonadotropin-production. A case report with immunohistochemical and ultrastructural analysis.
    Aru A; Rasmussen LA; Federspiel B; Horn T
    Am J Surg Pathol; 1996 Feb; 20(2):187-92. PubMed ID: 8554108
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.
    Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
    Ann Oncol; 1995 Jul; 6(6):581-7. PubMed ID: 8573538
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Characterization of four newly established human colorectal adenocarcinoma cell lines from Chinese patients.
    Cheng JY; Meng CL; Lin JC; Tzeng CC; Chin LT; Shen KL
    J Surg Oncol; 1990 Aug; 44(4):260-7. PubMed ID: 1696674
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors.
    Birkenfeld S; Noiman G; Krispin M; Schwartz S; Zakut H
    Eur J Surg Oncol; 1989 Apr; 15(2):103-8. PubMed ID: 2703054
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.